|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03320 CHINARES PHARMA
Nominal 
4.850 -0.110 (-2.218%) Ranking Overview
Ranking based on 4 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
4
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2024 | EPS | 53.00 RMB (cts) | |
| Net Profit | 3,350.86 RMB (MIL) | DPS | 13.50 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2025 | 3,665.50 | 58.35 | 14.95 | -- | 4,816.34 | 3,630.00 |
| 2026 | 4,020.50 | 63.75 | 16.15 | -- | 5,013.79 | 3,922.00 |
| 2027 | 4,329.50 | 68.95 | 17.50 | -- | 4,457.00 | 4,202.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | 3,630.00 | 58.00 | 15.00 | UBS | Buy | 8.60 | 27/03/2025 | |
| 2025 | 4,816.34 | 78.00 | 19.14 | MORGAN STANLEY | Overweight | 7.50 | 01/04/2025 | |
| 2025 | 3,645.00 | 58.00 | 6.00 | CICC | OutPerform | 7.00 | 28/03/2025 | |
| 2025 | 3,686.00 | 58.70 | 14.90 | BANK OF AMERICA | Buy | 6.20 | 28/03/2025 | |
| 2026 | 3,922.00 | 62.00 | 16.00 | UBS | -- | -- | 27/03/2025 | |
| 2026 | 5,013.79 | 81.00 | 20.08 | MORGAN STANLEY | -- | -- | 01/04/2025 | |
| 2026 | 3,988.00 | 63.00 | 6.00 | CICC | -- | -- | 28/03/2025 | |
| 2026 | 4,053.00 | 64.50 | 16.30 | BANK OF AMERICA | -- | -- | 28/03/2025 | |
| 2027 | 4,202.00 | 67.00 | 17.00 | UBS | -- | -- | 27/03/2025 | |
| 2027 | 4,457.00 | 70.90 | 18.00 | BANK OF AMERICA | -- | -- | 28/03/2025 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 16/04/2025 17:27 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 3,350,857 |
| %Change | -13.061% |
| EPS / (LPS) | RMB 0.530 |
| NBV Per Share (¥) | RMB 7.679 |